Skip to content

Bacopa did not outperform placebo on the trial’s main cognitive tests

Adults reporting memory and attention problems showed no detected cognitive advantage, although some secondary stress and fatigue measures favored the extract.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Bacopa did not show greater improvement than placebo in verbal learning, attention or working memory. Some secondary measures of stress and fatigue favored the extract, but those signals need further study. Self-reported adverse reactions were more frequent with Bacopa, mainly digestive complaints and headaches, despite no serious reactions being reported.

Keep in mind

This abstract-based summary reflects results from 87 participants with complete data, rather than everyone randomized. The abstract gives no effect sizes or confidence intervals for the cognitive results, limiting assessment of their precision.

THE RESULT, WITH CONTEXT

What researchers found

No significant between-group differences

Verbal learning, attention and working memory

Bacopa versus placebo after 12 weeks; primary cognitive outcomes analyzed among 87 participants with complete data.

Clin Drug Investig, 2025 · Original source ↓

Which outcomes came first

The trial prioritized cognitive tasks assessing learning, attention and working memory. Self-reported memory, mood and fatigue were secondary outcomes, and researchers also examined blood markers alongside the task and questionnaire results.

How to read the mixed results

The blood markers showed no detected differences between groups. Favorable secondary stress and fatigue results do not establish a memory benefit, while the primary findings also do not prove that the treatments are equivalent.

CHECK THE ORIGINAL

The original publication

The Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.

Lopresti AL, Smith SJ
Clin Drug Investig · 2025

PubMed ID
41091332
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.